---
title: Quality
parent: Rigor
---

---

**NOTE:** often mistagged as an adjective (e.g., *quality control*, *quality assurance*). These are not adjective uses.

---

### **1. Value-judgement**  
Usually yes when used adjectivally (signals desirability or standard).  
NOT a value-judgement in set technical phrases (e.g., *quality control*, *quality assurance*) or where *high-quality* functions as a technical descriptor (e.g., *high-quality mtDNA*).

<details markdown="1">
<summary><em>Examples</em></summary>

- *Next, we will establish a high **quality** biorepository of postmortem derived tissues …* (value-judgement)

- *Quality control procedures were implemented throughout the study.* (NOT adjective use)

</details>

---

### **2. Hyperbolic**  
Not inherently hyperbolic.

<details markdown="1">
<summary><em>Examples</em></summary>

NA

</details>

---

### **3a. Gratuitous**  
Often gratuitous, especially in *high-quality* constructions, unless grounds are given.

<details markdown="1">
<summary><em>Examples</em></summary>

- *Next, we will establish a high **quality** biorepository of postmortem derived tissues …* (gratuitous)

</details>

---

### **3b. Amplified**  
Often amplified via *high-quality* (and sometimes further by *very*, *extremely*, etc.).

<details markdown="1">
<summary><em>Examples</em></summary>

- *…a high **quality** biorepository …*

</details>

---

### **3c. Broader context**  
Often coordinated or stacked with other positive descriptors.

<details markdown="1">
<summary><em>Examples</em></summary>

- *…high-quality, comprehensive clinical data …*

</details>

---

### **3d. Grounds**  
Occasionally grounded when explicit criteria or standards are given; otherwise uncommon.

<details markdown="1">
<summary><em>Examples</em></summary>

NA

</details>

---

### **3e. Relative / Hedged**  
Sometimes appears in gap-marking or limiting contexts that reduce promotional force.

<details markdown="1">
<summary><em>Examples</em></summary>

- *Effective control of TB is critically hindered by the lack of **quality** diagnostics , a protective vaccine , and chemotherapy regimens with potency for drug-resistant TB patients .*

</details>
